Proliferation, Apoptosis, and Telomerase Activity in Human Cord Blood CD34+ Cells Cultured with Combinations of Various Cytokines

  • Ahn, Myung-Ju (Department of Internal Medicine, Hanyang University, College of School) ;
  • Lee, Hye-Sook (Department of Internal Medicine, Hanyang University, College of School) ;
  • Jang, Mi-Yune (Biochemistry, Hanyang University, College of School) ;
  • Choi, Jung-Hye (Department of Internal Medicine, Hanyang University, College of School) ;
  • Lee, Young-Yeul (Department of Internal Medicine, Hanyang University, College of School) ;
  • Park, Hyung-Bae (Department of Internal Medicine, Hanyang University, College of School) ;
  • Lee, Yong-Sung (Biochemistry, Hanyang University, College of School)
  • Published : 2003.06.01

Abstract

Umbilical cord blood (UCB), a rich source of hematopoietic stem/progenitor cells, has been proposed as an alternative to bone marrow and peripheral blood for transplantation treatment. Ex vivo expansion of cord blood stem cells could make the use of cord blood transplant feasible even for adult patients. However, the optimal cytokine cocktail for expansion of stem cells is yet to be established. This study compares proliferation, apoptosis, and telomerase activities in human cord blood stem cells cultured ex vivo with FLT3 ligand (FL)/thrombopoietin (TPO) or FL/TPO/stem cell factor (SCF), with a view to determine optimal combination of cytokines. CD34+ cells were cultured in DMEM containing either FL (50 ng/ml) and TPO (10 ng/ml) (FT group) or FL (50 ng/ml), TPO (10 ng/ml) and SCF (50 ng/ml) (FTS group). The cell proliferation rate was ten times higher in the FTS group. Although cells cultured with the two different combinations of cytokines were maintained for a long term (up to 8 weeks), a large number of cells underwent differentiation during this period. Cells cultured in FTS displayed lower levels of apoptosis compared to those of the FT group during the Initial 7 days of culture. The CD34+ fraction in both groups was markedly decreased to $21-30\%$ , and only $5-6\%$ was detected at 14 days of culture. Telomerase activity detected in human CD34+ cord blood at low levels was upregulated during the early phase of culture and decreased to baseline levels in the later phase. The telomerase activity of cord blood cultured in FT was lower than that of the FTS group. Our results suggest that, on adding stem cell factors to the FT cytokines, cultured CD34+ cord blood cells display a greater degree of cell proliferation and decreased apoptosis. However, during CD34+ cord blood cell culture, a Barge number of cells undergo differentiation, indicating that more potent novel cytokines or new culture conditioning methods should be developed to maintain their ability to engraft and sustain long-term hematopoiesis.

Keywords

References

  1. Blood v.90 Stem cell factor and hematopoiesis Broudy,V.C.
  2. Proc. Natl. Acad. Sci. USA v.89 Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults Broxmeyer,H.;G.Hangoc;S.Cooper;R.Ribeiro;V.Graves;M.Yoder;J.Wagner;S.Vadhan-Raj;L.Benninger;P.Rubinstein;E.Broun https://doi.org/10.1073/pnas.89.9.4109
  3. Int. J. Cell Cloning v.8 Human umbilical cord blood: A clinically useful source of transplantable hematopoietic stem/progenitor cells Broxmeyer,H.E.;E.Gluckman;A.D.Auerbach;G.W.Douglas;H.Friedman;S.Cooper;G.Hangoc;J.Kurtzberg;J.Bard;E.A.Boyse https://doi.org/10.1002/stem.5530080708
  4. Stem Cells v.14 Differential expression of telomerase activity in hematopoietic progenitors form adult bone marrow Chiu,C.P.;W.Dragowska;N.W.Kim;H.Vaziri;J.Yui;T.E.Thomas;C.B.Harley;P.M.Lansdorp https://doi.org/10.1002/stem.140239
  5. Exp. Hematol. v.22 The effect of cytokines on CD34+Rh-123 high and low progenitor cells from human umbilical cord blood Cicuttini,F.M.;K.L.Welch;A.W.Boyd
  6. Blood v.89 FLT3 ligand preserves the ability of human CD34+ progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction Dao,M.A.;C.H.Hannum;D.B.Kohn;J.A.Nolta
  7. Blood v.85 The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets Debili,N.;F.Wendling;D.Cosman;M.Titeux;C.Florindo;I.Dusanter-Fourt;K.Schooley;N.Methia;M.Charon;R.Nador;A.Bettaieb;W.Vainchenker
  8. J. Clin. Invest. v.76 Purification of fetal hemopoietic progenitors and demonstration of recombinant multipotential colony-stimulating activity Emerson,S.G.;C.A.Sieff;E.A.Wang;G.G.Wong;S.C.Clark;D.G.Nathan https://doi.org/10.1172/JCI112087
  9. Blood v.90 Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells Engelhardt,M.;R.Kumar;J.Albanell;R.Pettengell;W.Han;M.A.Moore
  10. N. Engl. J. Med. v.321 Hematopoietic reconstitution in a patient with Fanconis anemia by means of umbilical cord blood from an HLA-identical sibling Gluckman,E.;H.Broxmeyer;A.Auerbach;H.Friedman;G.Douglas;A.Devergie;H.Esperou;D.Thierry;G.Socie;P.Lehn;S.Cooper;D.English;J.Kurtzberg;J.Bard;E.Boyse https://doi.org/10.1056/NEJM198910263211707
  11. Int. J. Oncol. v.16 Detection of telomerase activity in human carcinomas using a TRAP-ELISA method: Correlation with hTR and hTERT expression Gonzalez-Quevedo,R.;de C.Juan;M.J.Massa;A.Sanchez-Pernaute;A.Torres;J.L.Balibrea;M.Benito;P.Iniesta
  12. Cell v.43 Identification of a specific telomere terminal transferase activity in Tetrahymena extracts Greider,C.W.;E.H.Blackburn https://doi.org/10.1016/0092-8674(85)90170-9
  13. Blood Cells v.20 Isolation and ex vivo expansion of CD34+ cells from cord blood using dextran sedimentation and avidin columm selection Heimfeld,S.;D.F.Kalamasz;B.L.Fogarty;R.Fei;Z.N.Tsui;H.M.Jones;R.J.Berenson
  14. J. Immunol. v.155 Activation of telomerase in human lymphocytes and hematopoietic progenitor cells Hiyama,K.;Y.Hirai;S.Kyoiuzumi;M.Akiyama;E.Hiyama;M.A.Poatzszek;J.W.Shay;S.Ishioka;M.Yamakido
  15. Science v.266 Specific association of human telomerase activity with immortal cells and cancer Kim,N.W.;M.A.Piatyszek;K.R.Prowse;C.B.Harley;M.D.West;P.L.Ho;G.M.Coviello;W.E.Wright;S.L.Weinrich;J.W.Shay https://doi.org/10.1126/science.7605428
  16. Exp. Hematol. v.28 In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34+ cord blood cells Kobari,L.;F.Pflumio;M.Giarratana;X.Li;M.Titeux;B.Izac;F.Leteurtre;L.Coulombel;L.Douay https://doi.org/10.1016/S0301-472X(00)00557-9
  17. J. Microbiol. Biotechnol. v.11 In vitro detection of apoptosis in human promyelocytic leukemia HL-60 cells by H-NMR Lee,C.H.;M.A.Lee;Y.Cho;H.Lim;J.Jung;K.Kim;Y.Lim
  18. Blood v.91 Thrombopoietin, kit ligand and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+ Thy-1+Lin-cells with preserved ability to engraft SCID-hubone Luens,K.M.;M.A.Travis;B.P.Chen;B.L.Hill;R.Scollay;L.J.Murray
  19. Blood v.91 c-kit ligand and flt3 ligand: Stem/progenitor cell factors with overlapping yet distinct activities Lyman,S.D.;S.E.W.Jacobsen
  20. Cell v.75 Molecular cloning of a ligand for the flt3/flk2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells Lyman,S.D.;L.James;T.Vanden Bos;de P. Vries;K.Brasel;B.Gliniak;L.T.Hollingsworth;K.S.Picha;H.J.McKenna;R.R.Splett;F.F.Fletcher;E.Maraskovsky;T.Farrah;D.Foxworthe;D.E.Williams;M.P.Bekmann https://doi.org/10.1016/0092-8674(93)90325-K
  21. Blood v.83 Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood Mayani,H.;P.M.Lansdorp
  22. Blood Cells v.20 Ex vivo expansion of cord blood-derived stem cells and progenitors Moore,M.A.;I.Hoskins
  23. Int. J. Hematol v.71 Down-regulation of human telomeric protein TRF1 gene expression during myeloid differentiation in human hematopoietic cells Otsuka,T.;N.Uchida;F.Arima;H.Shigematsu;T.Fukuyama;M.Maeda;Y.Sugio;Y.Itoh;Y.Niho
  24. Blood v.89 Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood Piacibello,W.;F.Sanavio;L.Garetto;A.Severino;D.Bergandi;J.Ferrario;F.Fagioli;M.Berger;M.Aglietta
  25. Oncogene v.6 Murine Flt3 a gene encoding novel tyrosine kinase receptor of the PDGFR/CSF1R family Rosnet,O.;S.Marchetto;de O.Lapierre;D.Birnbaum
  26. Proc. Natl. Acad. Sci. USA v.91 STK1, the human homologue of Flk2/FlT3 is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells Small,D.;M.Levenstein;E.Kim;C.Carow;A.Amin;P.Rockwell;L.Witte;C.Burrow;M.Z.Ratajczak;A.M.Gerwitz;C.I.Civin https://doi.org/10.1073/pnas.91.2.459
  27. J. Microbiol. Biotechnol. v.12 Adenovirus-mediated antisense expression of telomerase template RNA induces apoptosis in lung cancer cells Song,J.S.;S.B.Kim;Y.H.Lee;K.W.Lee;H.H.Jung;M.H.Kim;K.T.Kim;R.Brown;Y.T.Kim
  28. Exp. Hematol. v.26 Proliferation-induced decline of primitive hematopoietic progenitor cell activity is coupled with an increase in apoptosis of ex vivo expanded CD34+ cells Traycoff,C.M.;A.Orazi;A.C.Ladd;S.Rice;J.McMahel;E.F.Srour
  29. Leuk. Res. v.23 Differential gene expression of human telomerase-associated protein hTERT and TEP1 in human hematopoietic cells Uchida,N.;T.Otsuka;H.Shigematsu;M.Maeda;Y.Sugio;Y.Itoh;Y.Niho https://doi.org/10.1016/S0145-2126(99)00149-6
  30. Proc. Natl. Acad. Sci. USA v.91 Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age Vaziri,H.;W.Dragowska;R.C.Allsopp;T.E.Thomas;C.B.Harley;P.M.Lansdorp https://doi.org/10.1073/pnas.91.21.9857